Purchase Order 75N92025P00001
Award Date
10/10/24
Potential Completion Date
10/9/25
Potential Value
$11K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Proteogenix
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
France
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
The National Heart Lung and Blood Institute (NHLBI) awarded a $81,200.00 firm fixed price purchase order contract to Second Genome, Inc. for MICROBIOME OPTIMIZED DNA ISOLATION SERVICES. The contract has a completion date of August 27, 2018 and is designated as a Total Small Business set-aside. Second Genome, Inc. is a self-certified small disadvantaged business. The NHLBI is a civilian agency that conducts and supports research related to the causes, prevention, diagnosis, and treatment of...
<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price Purchase Order to Proteogenix, a for-profit manufacturer, to provide phage-display library screening services to develop in vivo gene therapy. The contract has a potential value of $46,260.00 and a completion date of April 21, 2025. The contract was awarded on April 22, 2024 and does not have a set-aside designation.</p>
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $14,097.60 firm fixed price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide transcriptome profiling of human bone marrow core samples. The work supports the Hematology Branch at NHLBI. This is not a set-aside contract. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities. The company has a $500 million single-award Indefinite...
<p>The National Heart Lung and Blood Institute (NHLBI), a civilian agency, has awarded a $120,000.00 firm fixed price purchase order contract to Bionik LLC for vector production and purification services. The contract has an ultimate completion date of October 31, 2024 and was awarded on September 1, 2023. This contract is not associated with any set-aside designation.</p>
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $17,000.00 firm fixed-price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for knock-out cell line generation services to support the agency's cell biology experiments. No set-aside designation was used. Synthego, a leading provider of advanced genetic engineering tools...
This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to NeoGenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory. The one-year, $1,101,929.74 firm fixed-price purchase order is for NeoGenomics to provide clinical diagnostic testing services to the NHLBI Division of Intramural Research (DIR). The contract does not have a set-aside designation, indicating it was...
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Genomic Testing Cooperative, LCA (GTC), a self-certified small disadvantaged business, for the provision of a 177-gene Hematology Panel. The $90,000.00 contract has an ultimate completion date of December 8, 2025 and supports the NHLBI's biomedical research initiatives, contributing to advancements in the understanding and treatment of various...